TG Therapeutics, Inc. Comparables
Find the most relevant public market comparables for TG Therapeutics, Inc., including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.
Company Overview
TG Therapeutics, Inc. is a fully integrated, commercial-stage biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. They have received FDA approval for BRIUMVI (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis.
Business Model
Acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases.
Target Customers
Adult patients with relapsing forms of multiple sclerosis (RMS), and potentially other patients with B-cell disorders in the future.
Specific Focus
Novel treatments for B-cell malignancies and autoimmune diseases, specifically relapsing forms of multiple sclerosis.
Location
New York, New York
CEO
Michael S. Weiss
Industry
Life sciences
Sub Sector
Biotechnology: Pharmaceutical Preparations
3yr Revenue Growth
153,625%
Website
Public Market Comparables
Below are the key valuation metrics for companies similar to TG Therapeutics, Inc. in the Healthcare sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.
Looking for a comprehensive compset for TG Therapeutics, Inc.? Our platform provides detailed analysis of TG Therapeutics, Inc.'s competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full TG Therapeutics, Inc. compset by trying our platform today.
EV/Revenue Multiple
Min
0.0x
Median
0.0x
Max
00.0x
Unlock actual values by trying our platform
View Full DetailsEV/EBITDA Multiple
Min
00.0x
Median
00.0x
Max
00.0x
Unlock actual values by trying our platform
View Full Details
Unlock the Full TG Therapeutics, Inc. Compset
As a leading player in the Life sciences industry within the Healthcare sector, TG Therapeutics, Inc. operates in the specialized Biotechnology: Pharmaceutical Preparations sub-sector. Understanding how TG Therapeutics, Inc. compares to its public market comps is essential for accurate valuation and strategic decision-making.
Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the Biotechnology: Pharmaceutical Preparations space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.
Other Interesting Companies
Vytalize Health
Healthcare • Life sciences
Vytalize Health is a risk-bearing provider enablement platform and leading Accountable Care Organization (ACO) that partners with primary care physicians (PCPs) to deliver value-based care, improving patient outcomes and reducing healthcare costs. They offer an all-in-one solution including value-based incentives, smart technology, and a virtual clinic, enabling independent practices to thrive in value-based care arrangements. The company focuses on Medicare patients and works with over 2,500 PCPs across 36 states.
Talkiatry
Healthcare • Life sciences
Talkiatry is a national mental health practice providing in-network psychiatry and therapy via telehealth. It utilizes technology and a human-centered approach to improve access to high-quality mental healthcare, addressing issues of accessibility and affordability.
PurposeMed
Health Tech • Life sciences
PurposeMed is a high-growth digital health company providing accessible and specialized healthcare services, focusing on underserved populations across Canada and the United States. They offer virtual healthcare solutions, connecting patients with specialized clinicians for various services, including HIV prevention, ADHD care and diagnosis, and gender-affirming care. Their model emphasizes compassionate, judgment-free care with a focus on eliminating barriers to access high-quality healthcare.
Get Your Custom Comparable Analysis
Need a more detailed analysis of TG Therapeutics, Inc. and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.
Try CompsetFinder Free